Chemoinformaics analysis of  Licoisoflavone-C
| Molecular Weight | 354.358 | nRot | 3 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 19 |
| Exact Molecular Weight | 354.11 | nRing | 3 |
| Solubility: LogS | -3.189 | nHRing | 1 |
| Solubility: LogP | 4.547 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 50.2143 |
| nHD | 4 | BPOL | 20.6617 |
| QED | 0.533 |
| Synth | 2.875 |
| Natural Product Likeliness | 2.064 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.659 |
| HIA | 0.01 |
| CACO-2 | -4.94 |
| MDCK | 0.00000889 |
| BBB | 0.004 |
| PPB | 0.968453 |
| VDSS | 0.598 |
| FU | 0.0354853 |
| CYP1A2-inh | 0.918 |
| CYP1A2-sub | 0.174 |
| CYP2c19-inh | 0.763 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.812 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.873 |
| CYP2d6-sub | 0.351 |
| CYP3a4-inh | 0.275 |
| CYP3a4-sub | 0.076 |
| CL | 8.418 |
| T12 | 0.831 |
| hERG | 0.027 |
| Ames | 0.128 |
| ROA | 0.364 |
| SkinSen | 0.94 |
| Carcinogencity | 0.091 |
| EI | 0.905 |
| Respiratory | 0.085 |
| NR-Aromatase | 0.847 |
| Antiviral | Yes |
| Prediction | 0.865869 |